The use status of anticoagulation drugs for inpatients with nonvalvular atrial fibrillation in Southwest China

References

• LipGYBrechinCMLaneDAThe global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and EuropeChest201214261489149822459778
   PubMed Web of Science ®Google Scholar
• ZhouZQHuDYChenJZhangRHLiKBZhaoXLAn epidemiological survey of atrial fibrillation in ChinaZhonghua Nei Ke Za Zhi2004437491494 Abstract in English15312400
   PubMedGoogle Scholar
• WolfPADawberTRThomasHEJrKannelWBEpidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham studyNeurology19782810973977570666
   PubMed Web of Science ®Google Scholar
• HartRGPearceLAAguilarMIMeta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med20071461285786717577005
   PubMed Web of Science ®Google Scholar
• van WalravenCHartRGSingerDEOral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysisJAMA2002288192441244812435257
   PubMed Web of Science ®Google Scholar
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trialsArch Intern Med199415413144914578018000
   PubMed Web of Science ®Google Scholar
• SunYHuDChinese Investigators of GARFIELDChinese Investigators of GARFIELDChinese subgroup analysis of the global anticoagulant registry in the FIELD (GARFIELD) registry in the patients with non-valvular atrial fibrillationZhonghua Xin Xue Guan Bing Za Zhi20144210846850 Chinese25549561
   PubMedGoogle Scholar
• AkaoMChunYHWadaHFushimi AF Registry InvestigatorsCurrent status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF RegistryJ Cardiol201361426026623403369
   PubMed Web of Science ®Google Scholar
• NieuwlaatRCapucciACammAJEuropean Heart Survey InvestigatorsAtrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial FibrillationEur Heart J200526222422243416204266
   PubMed Web of Science ®Google Scholar
• OgilvieIMNewtonNWelnerSACowellWLipGYUnderuse of oral anticoagulants in atrial fibrillation: a systematic reviewAm J Med20101237638645.e420609686
   PubMed Web of Science ®Google Scholar
• FusterVRydenLECannomDS2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm SocietyJ Am Coll Cardiol20115711e101e19821392637
   PubMed Web of Science ®Google Scholar
• Wen-HangQISociety of Cardiology, Chinese Medical AssociationRetrospective investigation of hospitalised patients with atrial fibrillation in mainland ChinaInt J Cardiol2005105328328716274769
   PubMed Web of Science ®Google Scholar
• LiuBLiuLZXuanJTreatment patterns associated with stroke prevention in patients with atrial fibrillation in three major cities in the People’s Republic of chinaInt J Gen Med20137293524379692
   PubMedGoogle Scholar
• WaldoALBeckerRCTapsonVFColganKJNABOR Steering CommitteeHospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulationJ Am Coll Cardiol20054691729173616256877
   PubMed Web of Science ®Google Scholar
• KirchhofPAmmentorpBDariusHManagement of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events–European Registry in Atrial Fibrillation (PREFER in AF)Europace201416161424084680
   PubMed Web of Science ®Google Scholar
• ConnollySPogueJHartRClopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialLancet200636795261903191216765759
   PubMed Web of Science ®Google Scholar
• ConnollySJPogueJHartRGACTIVE InvestigatorsEffect of clopidogrel added to aspirin in patients with atrial fibrillationN Engl J Med2009360202066207819336502
   PubMed Web of Science ®Google Scholar
• MantJHobbsFDFletcherKBAFTA investigatorsMidland Research Practices Network (MidReC)Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trialLancet2007370958649350317693178
   PubMed Web of Science ®Google Scholar
• van WalravenCHartRGConnollySEffect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigatorsStroke20094041410141619182090
   PubMed Web of Science ®Google Scholar
• LeeVWTamCSYanBPManYCYinLYBarriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong KongClin Cardiol201336316617123151816
   PubMed Web of Science ®Google Scholar
• ChoudhryNKAndersonGMLaupacisARoss-DegnanDNormandSLSoumeraiSBImpact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysisBMJ2006332753414114516403771
   PubMed Web of Science ®Google Scholar
• Man-Son-HingMLaupacisAAnticoagulant-related bleeding in older persons with atrial fibrillation: physicians’ fears often unfoundedArch Intern Med2003163131580158612860581
   PubMed Web of Science ®Google Scholar
• FullerRDudleyNBlacktopJRisk communication and older people-understanding of probability and risk information by medical inpatients aged 75 years and olderAge Ageing200130647347611742775
   PubMed Web of Science ®Google Scholar
• KaganskyNKnoblerHRimonEOzerZLevySSafety of anticoagulation therapy in well-informed older patientsArch Intern Med2004164182044205015477441
   PubMed Web of Science ®Google Scholar
• KimmelSEChenZPriceMThe influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) StudyArch Intern Med2007167322923517296877
   PubMed Web of Science ®Google Scholar
• LaneDAPonsfordJShelleyASirpalALipGYPatient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation ProjectInt J Cardiol2006110335435816253356
   PubMed Web of Science ®Google Scholar
• MillerNHCompliance with treatment regimens in chronic asymptomatic diseasesAm J Med19971022A43499217586
   PubMedGoogle Scholar
• RuffCTGiuglianoRPBraunwaldEComparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsLancet2014383992195596224315724
   PubMed Web of Science ®Google Scholar
• WangYCuiLJiXThe China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristicsInt J Stroke20116435536121609414
   PubMed Web of Science ®Google Scholar